From: Controlled ovarian stimulation in cancer patients under 18 years old; a case series
Case | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
COS Protocol | GnRH antagonist | |||||||||
Stimulation cycle start | Early. Pb | Luteal Phasec | Early. Pd | Late. Pe | Early. P | |||||
Gonadotropins | recombinant-FSH | |||||||||
Starting gonadotropin dose (IU) | 150 | 225 | 150 | 150 | 150 | 150 | 150 | 112.5 | 150 | 150 |
Total gonadotropin dose (IU) | 1050 | 2025 | 1350 | 1500 | 1200 | 1650 | 1425 | 1687.5 | 1350 | 1350 |
GnRH-antagonist (ampule) | 4 | 4 | 5 | 6 | 4 | 8 | 3 | 9 | 6 | 5 |
Duration of stimulation (day) | 8 | 10 | 10 | 11 | 9 | 12 | 9 | 14 | 10 | 11 |
Follicle> 12 mma | 10 | 6 | 12 | 11 | 13 | 17 | 11 | 13 | 8 | 22 |
Triggering medication | 2recombinant-HCG | Low dose GnRH-agonist | ||||||||
Total oocytes retrieved | 13 | 10 | 9 | 10 | 21 | 6 | 8 | 0 | 32 | 33 |
Total mature oocytes (MII) | 13 | 10 | 9 | 8 | 17 | 5 | 5 | 0 | 26 | 23 |
Total oocytes cryopreservation | 13 | 5 | 9 | 8 | 20f | 0 | 7f | 0 | 26 | 23 |
Total embryos cryopreservation | - | 5 | - | - | - | 5 | - | - | - | - |
OHSS & others side effects | No |